127P Atezolizumab (A) + Pertuzumab + Trastuzumab (PH) + Chemotherapy (CT) in HER2-positive Early Breast Cancer (HER2+ Ebc): Final Results of the Phase III IMpassion050 Trial
ESMO Open(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ESMO Open(2024)